NCI | Technology Transfer

METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY

Read more about METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY

United Kingdom
14718255.4
Filed on 2014-03-13

METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY

Read more about METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY

Germany
14718255.4
Filed on 2014-03-13

METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY

Read more about METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY

France
14718255.4
Filed on 2014-03-13

Synthetic Lethality-Mediated Precision Oncology via the Tumor Transcriptome

Read more about Synthetic Lethality-Mediated Precision Oncology via the Tumor Transcriptome

US Application 18/250,816
Filed on 2023-04-27

METHODS FOR TREATING INFECTIONS

Read more about METHODS FOR TREATING INFECTIONS

US Patent 12,374,435
Filed on 2023-03-14

PLK1 POLO DOMAIN INHIBITORS AND METHOD OF TREATING CANCER

Read more about PLK1 POLO DOMAIN INHIBITORS AND METHOD OF TREATING CANCER

European Patent
21795110.2
Filed on 2023-04-19

PLK1 POLO BOX DOMAIN INHIBITOR AND METHOD OF TREATING CANCER

Read more about PLK1 POLO BOX DOMAIN INHIBITOR AND METHOD OF TREATING CANCER

Canada
3193855
Filed on 2023-03-24

PLK1 POLO BOX DOMAIN INHIBITORS AND METHOD OF TREATING CANCER

Read more about PLK1 POLO BOX DOMAIN INHIBITORS AND METHOD OF TREATING CANCER

US Application 18/028,463
Filed on 2023-03-24

PLK1 POLO BOX DOMAIN INHIBITORS AND METHOD OF TREATING CANCER

Read more about PLK1 POLO BOX DOMAIN INHIBITORS AND METHOD OF TREATING CANCER

Australia
2021350736
Filed on 2023-04-18

CANCER IMMUNOTHERAPY BY DELIVERING CLASS II MHC ANTIGENS USING A VLP-REPLICON

Read more about CANCER IMMUNOTHERAPY BY DELIVERING CLASS II MHC ANTIGENS USING A VLP-REPLICON

US Patent 12,049,639
Filed on 2023-02-24

Subscribe to NCI